Published in Behav Res Ther on October 10, 2013
A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION. Depress Anxiety (2015) 0.95
Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder. Expert Rev Neurother (2014) 0.82
Components of Cognitive Behavioral Therapy Related to Outcome in Childhood Anxiety Disorders. Clin Child Fam Psychol Rev (2015) 0.81
Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial. Eur Child Adolesc Psychiatry (2014) 0.80
Efficacy of Cognitive-Behavioral Therapy in Pediatric Obsessive-Compulsive Disorder: A Meta-Analysis. Med Sci Monit (2016) 0.79
A pilot trial of cognitive-behavioral therapy augmentation of antibiotic treatment in youth with pediatric acute-onset neuropsychiatric syndrome-related obsessive-compulsive disorder. J Child Adolesc Psychopharmacol (2015) 0.78
Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial. J Psychiatr Res (2015) 0.77
Characteristics of Young Children with Obsessive-Compulsive Disorder: Baseline Features from the POTS Jr. Sample. Child Psychiatry Hum Dev (2016) 0.76
Secondary outcomes from the pediatric obsessive compulsive disorder treatment study II. J Psychiatr Res (2017) 0.75
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry (1997) 41.93
The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry (1997) 8.76
Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry (1997) 7.10
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry (2005) 3.38
Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials. Am J Psychiatry (2009) 2.43
A family study of obsessive-compulsive disorder. Am J Psychiatry (1995) 2.24
Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol (2003) 2.13
Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry (2005) 1.80
Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale. Psychiatry Res (2004) 1.48
Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. Br J Psychiatry (1988) 1.30
Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale. J Am Acad Child Adolesc Psychiatry (2010) 1.29
Barriers to treatment and service utilization in an internet sample of individuals with obsessive-compulsive symptoms. Depress Anxiety (2010) 1.16
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? J Child Adolesc Psychopharmacol (2003) 1.02
SSRI adverse events: how to monitor and manage. Int Rev Psychiatry (2008) 1.01
Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study. Br J Psychiatry Suppl (1998) 1.00
Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. J Nerv Ment Dis (1998) 1.00
A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. Int Clin Psychopharmacol (1990) 0.95
Clomipramine and exposure for obsessive-compulsive rituals: i. Br J Psychiatry (1980) 0.86
Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder. Expert Opin Pharmacother (2004) 0.78
Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med (2014) 4.88
Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology (2005) 3.03
Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain (2012) 2.99
Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology (2006) 2.58
Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol (2005) 2.52
Review and meta-analysis of couple-oriented interventions for chronic illness. Ann Behav Med (2010) 2.47
Impact of coping skills intervention with family caregivers of hospice patients with cancer: a randomized clinical trial. Cancer (2006) 2.44
Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med (2015) 2.42
Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol (2012) 2.33
Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry (2007) 2.05
The relation between family factors and metabolic control: the role of diabetes adherence. J Pediatr Psychol (2005) 2.00
Family accommodation in pediatric obsessive-compulsive disorder. J Clin Child Adolesc Psychol (2007) 1.91
Validity and reliability of an adolescent and parent rating scale of type 1 diabetes adherence behaviors: the Self-Care Inventory (SCI). J Pediatr Psychol (2009) 1.80
Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement (2011) 1.71
Peer victimization, psychosocial adjustment, and physical activity in overweight and at-risk-for-overweight youth. J Pediatr Psychol (2006) 1.70
Rage attacks in pediatric obsessive-compulsive disorder: phenomenology and clinical correlates. J Am Acad Child Adolesc Psychiatry (2012) 1.69
Glycemic control in youth with type 1 diabetes: family predictors and mediators. J Pediatr Psychol (2008) 1.67
Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care medicaid program. J Am Acad Child Adolesc Psychiatry (2010) 1.55
Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol (2002) 1.55
Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol (2007) 1.51
Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry (2008) 1.50
Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale. Psychiatry Res (2004) 1.48
Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety (2010) 1.47
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol (2007) 1.46
Decreased family accommodation associated with improved therapy outcome in pediatric obsessive-compulsive disorder. J Consult Clin Psychol (2009) 1.44
Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer (2005) 1.44
Longitudinal predictors of driving cessation among older adults from the ACTIVE clinical trial. J Gerontol B Psychol Sci Soc Sci (2008) 1.42
Reliability and validity of the Yale Global Tic Severity Scale. Psychol Assess (2005) 1.41
Symptom distress and quality of life in patients with cancer newly admitted to hospice home care. Oncol Nurs Forum (2002) 1.39
Evaluation of open-label topiramate for scar therapy. Dermatol Online J (2003) 1.38
Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial. Oncol Nurs Forum (2007) 1.38
The role of mastery and social resources in the associations between disability and depression in later life. Gerontologist (2002) 1.34
Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry (2002) 1.33
Correlates of comorbid anxiety and externalizing disorders in childhood obsessive compulsive disorder. Eur Child Adolesc Psychiatry (2010) 1.31
Trichotillomania: A current review. Clin Psychol Rev (2009) 1.30
Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychol (2007) 1.29
Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale. J Am Acad Child Adolesc Psychiatry (2010) 1.29
Fatigue after treatment for early stage breast cancer: a controlled comparison. Cancer (2007) 1.28
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry (2010) 1.27
Behavioral treatment of self-injury, 1964 to 2000. Am J Ment Retard (2002) 1.25
Determinants of a sense of mastery in African American and White older adults. J Gerontol B Psychol Sci Soc Sci (2003) 1.25
Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry (2006) 1.25
The influence of APOE status on episodic and semantic memory: data from a population-based study. Neuropsychology (2006) 1.25
What's in a "smile?" Intra-operative observations of contralateral smiles induced by deep brain stimulation. Neurocase (2004) 1.23
The effect of cognitive-behavioral therapy versus treatment as usual for anxiety in children with autism spectrum disorders: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry (2013) 1.23
Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3-year follow-up period. Dement Geriatr Cogn Disord (2009) 1.22
Quality of life in youth with Tourette's syndrome and chronic tic disorder. J Clin Child Adolesc Psychol (2007) 1.21
Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory. J Pain Symptom Manage (2008) 1.21
Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer (2009) 1.20
A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry (2010) 1.20
Brain activation by disgust-inducing pictures in obsessive-compulsive disorder. Biol Psychiatry (2003) 1.20
A measure of functional impairment in youth with Tourette's syndrome. J Pediatr Psychol (2007) 1.19
Refining clinical judgment of treatment outcome in obsessive-compulsive disorder. Psychiatry Res (2010) 1.18
Comparing effects of kyphoplasty, vertebroplasty, and non-surgical management in a systematic review of randomized and non-randomized controlled studies. Eur Spine J (2012) 1.17
The children's Yale-Brown obsessive-compulsive scale: psychometric properties of child- and parent-report formats. J Anxiety Disord (2006) 1.16
Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biol Psychiatry (2004) 1.16
Varenicline effects on craving, cue reactivity, and smoking reward. Psychopharmacology (Berl) (2011) 1.15
Clinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorder. Clin Psychol Rev (2007) 1.15
Maternal efforts to prevent type 1 diabetes in at-risk children. Diabetes Care (2005) 1.15
Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr (2011) 1.14
Predictors of six-month survival among patients with dementia: an evaluation of hospice Medicare guidelines. Am J Hosp Palliat Care (2003) 1.13
Ethnic differences in diffuse noxious inhibitory controls. J Pain (2008) 1.13
It's never too late to engage in lifestyle activities: significant concurrent but not change relationships between lifestyle activities and cognitive speed. J Gerontol B Psychol Sci Soc Sci (2007) 1.12
Predictors of functional impairment in pediatric obsessive-compulsive disorder. J Anxiety Disord (2009) 1.11
Preliminary investigation of web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder. Psychiatry Res (2011) 1.10
Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis. Support Care Cancer (2014) 1.10
Impact of breast cancer survivorship on quality of life in older women. Crit Rev Oncol Hematol (2006) 1.10
Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison. Support Care Cancer (2012) 1.08